Rinaldo Del Bono

Rinaldo Del Bono, founder of Mediolanum farmaceutici in 1972 in Milan, Italy, is an entrepreneur and executive within the pharmaceutical industry. His vision, since the founding days, was to distribute the company’s own products internationally and to significantly invest in innovation. Mediolanum farmaceutici is now a pharmaceutical group comprised of a dozen companies including Leurquin-Mediolanum Laboratories and Elsalys Biotech in France. In the past few years, the Mediolanum group has increased its R&D efforts by investing in several projects covering various therapeutic areas such as rheumatoid arthritis, endocrinology, ophthalmology and anti-cancer vaccination. Mediolanum has been an early investor in Acticor Biotech and glenzocimab R&D since 2016.